Company Profile
Kindstar Globalgene Technology, Inc., an investment holding company provides clinical testing services in the People's Republic of China and Mainland China. Its business is organized into nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others.
The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases, as well as product development and technical services. Its portfolio also includes reagent development and sales, car-t treatment, and E-commerce services.
The company's R&D projects, including molecular biology detection, flow cytometry detection, cytogenetic detection, and pathological detection technologies. Founded in 2003, Kindstar Globalgene Technology is headquartered in Wuhan, the People's Republic of China.